M Lataillade, JP Lalezari,
M Kozal, JA Aberg… - The Lancet …, 2020 - thelancet.com
Background Fostemsavir, a prodrug of the first-in-class attachment inhibitor, temsavir, is
indicated for heavily treatment-experienced individuals with multidrug-resistant HIV-1. We …